By: IPP Bureau
Last updated : August 03, 2021 2:32 pm
Robust demand for the product across the Middle East, Africa and Latin America
Evexia Lifecare has been permitted by the FDA to produce Active Pharmaceutical Ingredient (API), of Isometamidium (Isometa). This API is used for treating diseases in cattle. There are limited players in this field and the company aims to set up the plant with a capacity of 400 kg per month API.
There is increased demand for this API in the Middle East, Africa and Latin America and the company expects that this would lead to an increase in revenue by Rs 30-40 crore.
The company has collaborated with Mr Avsari and Mr Deepak Yarde well-known scientists in this field. It has also set up an R&D Laboratory at its Vadodra plant.
Evexia Lifecare will also market this product globally as there is a huge potential for this API and the demand is expected to grow in the coming years.